These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2546369)

  • 1. Use of continuous subcutaneous growth hormone-releasing hormone (GHRH (1-29)NH2) infusions to augment growth hormone secretion and to promote growth.
    Brain C; Hindmarsh PC; Pringle PJ; Brook CG
    Acta Paediatr Scand Suppl; 1989; 349():109-13; discussion 123-4. PubMed ID: 2546369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of 24-hour growth hormone secretion after continuous subcutaneous infusion of growth hormone-releasing hormone (GHRH (1-29)NH2) in short children with low 24-hour growth hormone secretion.
    Tauber MT; Pienkowski C; Landier F; Gunnarsson R; Rochiccioli P
    Acta Paediatr Scand Suppl; 1989; 349():117-22; discussion 123-4. PubMed ID: 2546370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous subcutaneous GHRH(1-29)NH2 promotes growth over 1 year in short, slowly growing children.
    Brain CE; Hindmarsh PC; Brook CG
    Clin Endocrinol (Oxf); 1990 Feb; 32(2):153-63. PubMed ID: 2140733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone releasing hormone or growth hormone treatment in growth hormone insufficiency?
    Smith PJ; Brook CG
    Arch Dis Child; 1988 Jun; 63(6):629-34. PubMed ID: 2898924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained improvement in growth velocity and recovery from suboptimal growth hormone (GH) secretion after treatment with human pituitary GH-releasing hormone-(1-44)-NH2.
    Lifshitz F; Lanes R; Pugliese M; Fort P; Perez I; Puentes S; Cervantes C; Gunczler P; Chasalow FI; Recker B
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1255-60. PubMed ID: 1430086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone (GH) profiles in response to continuous subcutaneous infusion of GH-releasing hormone(1-29)-NH2 in children with GH deficiency.
    Tauber MT; Pienkowski C; Pigeon P; Cataldi M; Rochiccioli P
    Acta Paediatr Suppl; 1993 Mar; 388():28-30; discussion 31. PubMed ID: 8329829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of growth hormone-releasing hormone in the diagnosis and treatment of short stature.
    Grossman A; Savage MO; Blacklay A; Ross RM; Plowman PN; Preece MA; Coy DH; Besser GM
    Horm Res; 1985; 22(1-2):52-7. PubMed ID: 2863206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses to analogues of growth hormone-releasing hormone in normal subjects, and in growth-hormone deficient children and young adults.
    Grossman A; Savage MO; Lytras N; Preece MA; Sueiras-Diaz J; Coy DH; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1984 Sep; 21(3):321-30. PubMed ID: 6236914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous treatment with growth hormone-releasing hormone for short stature.
    Hernández M; Fragoso J; Barrio R; Argente J; Arilla E
    Horm Res; 1988; 30(6):252-7. PubMed ID: 2907992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of growth hormone releasing hormone therapy and growth hormone therapy in growth hormone deficiency.
    Butenandt O; Staudt B
    Eur J Pediatr; 1989 Feb; 148(5):393-5. PubMed ID: 2537727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyridostigmine fails to increase either spontaneous or GHRH-stimulated GH secretion during day or night in growth hormone-insufficient children.
    Kirk JM; Ross RJ; Trainer PJ; Froud AL; Davies SC; Savage MO; Besser GM
    Clin Endocrinol (Oxf); 1991 May; 34(5):407-11. PubMed ID: 2060150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth response to growth hormone-releasing hormone(1-29)-NH2 compared with growth hormone.
    Neyzi O; Yordam N; Ocal G; Bundak R; Darendeliler F; Açikgöz E; Berberoğlu M; Günöz H; Saka N; Calikoğlu AS
    Acta Paediatr Suppl; 1993 Mar; 388():16-21; discussion 22. PubMed ID: 8329826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of intranasal insufflation of growth hormone releasing factor analogue GRF 1-29 NH2 on growth hormone secretion in children with short stature.
    Borkenstein M
    Acta Endocrinol Suppl (Copenh); 1986; 279():135-8. PubMed ID: 2877535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone (GH) release after administration of GH-releasing hormone in relation to endogenous 24-h GH secretion in short children.
    Gelander L; Albertsson-Wikland K
    J Endocrinol; 1989 Jul; 122(1):61-8. PubMed ID: 2549156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of growth hormone (GH) and GH-releasing hormone(1-29)-NH2 for stimulation of growth in children with GH deficiency.
    Chen RG; Shen YN; Yei J; Wang CF; Xie DH; Wang XH; Zhou JD; Chen CY; Wu YL; Gunnarsson R
    Acta Paediatr Suppl; 1993 Mar; 388():32-5; discussion 36. PubMed ID: 8329830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of growth-hormone deficiency with growth-hormone-releasing hormone.
    Ross RJ; Rodda C; Tsagarakis S; Davies PS; Grossman A; Rees LH; Preece MA; Savage MO; Besser GM
    Lancet; 1987 Jan; 1(8523):5-8. PubMed ID: 2879138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous growth hormone-releasing hormone augments pulsatile nocturnal GH release in GH-insufficient children, but may also raise basal GH secretion.
    Ross RJ; Kirk JM; Tsagarakis S; Trainer PJ; Ciccarelli E; Touzel R; Grossman A; Savage MO; Besser GM
    Clin Endocrinol (Oxf); 1990 Aug; 33(2):239-48. PubMed ID: 2225481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone response to overnight growth hormone-releasing hormone infusion and oral pyridostigmine in children with short stature.
    Ross RJ; Savage MO; Kirk JM; Besser GM
    Acta Paediatr Scand Suppl; 1989; 349():114-6; discussion 123-4. PubMed ID: 2501967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone-releasing hormone in the diagnosis and treatment of growth hormone deficient children.
    Ross RJ; Grossman A; Besser GM; Savage MO
    Acta Endocrinol Suppl (Copenh); 1986; 279():123-9. PubMed ID: 3096037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction between clonidine and growth hormone releasing hormone in the stimulation of growth hormone secretion in man.
    Suri D; Hindmarsh PC; Brain CE; Pringle PJ; Brook CG
    Clin Endocrinol (Oxf); 1990 Sep; 33(3):399-406. PubMed ID: 2147600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.